According to FibroGen's latest financial reports the company's current EPS (TTM) is -$5.35. In 2022 the company made an earnings per share (EPS) of -$4.95 a decrease over its 2021 EPS that were of -$4.95.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.10 | 2.9% |
2022 | -$4.95 | -0% |
2021 | -$4.95 | 48.11% |
2020 | -$3.35 | 140.91% |
2019 | -$1.39 | -14.56% |
2018 | -$1.63 | -32.68% |
2017 | -$2.41 | 64.52% |
2016 | -$1.47 | -34.51% |
2015 | -$2.24 | -6.98% |
2014 | -$2.41 |